Search research articles
Contact Us
Filters
Showing results (11-20 of 198) with videos related to
Page
of 20
Sort By:
Journal of the American Society of Nephrology : JASN
|
September 15, 2012
Partial answers from partial Klotho deficiency
Tamara Isakova, Myles Wolf
Current Opinion in Nephrology and Hypertension
|
May 20, 2020
Editorial: New and repurposed therapeutics for mineral, stone and vascular disorders
Tamara Isakova, Aline Martin
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 26, 2024
Reducing Elevated Parathyroid Hormone to Protect Bone Strength in End-Stage Kidney Disease
Tamara Isakova, Thomas L Nickolas
Current Opinion in Nephrology and Hypertension
|
April 28, 2018
Management of stones and bones: reduction of uncertainty through research
Tamara Isakova, David A Bushinsky
Kidney International
|
October 30, 2010
FGF23 or PTH: which comes first in CKD ?
Tamara Isakova, Myles S Wolf
Clinical Journal of the American Society of Nephrology : CJASN
|
August 21, 2007
Calcium, calcimimetics and clinical outcomes
Geoffrey Block
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 26, 2022
A Klotho-Derived Peptide as a Possible Novel Drug to Prevent Kidney Fibrosis
Tamara Isakova, Christopher Yanucil, Christian Faul
Clinical Journal of the American Society of Nephrology : CJASN
|
May 11, 2018
Microbiome and Cardiovascular Disease in CKD
Anna Jovanovich, Tamara Isakova, Jason Stubbs
Journal of the American Heart Association
|
August 23, 2023
Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney Disease
Daniel Edmonston, Tamara Isakova, Myles Wolf, et al.
Kidney International
|
July 17, 2009
A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease
Tamara Isakova, Orlando M Gutiérrez, Myles Wolf
Page
of 20
Search research articles
Search
Showing results (11-20 of 198) with videos related to
Sort By:
Page
of 20
Journal of the American Society of Nephrology : JASN
|
September 15, 2012
Partial answers from partial Klotho deficiency
Tamara Isakova, Myles Wolf
Current Opinion in Nephrology and Hypertension
|
May 20, 2020
Editorial: New and repurposed therapeutics for mineral, stone and vascular disorders
Tamara Isakova, Aline Martin
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 26, 2024
Reducing Elevated Parathyroid Hormone to Protect Bone Strength in End-Stage Kidney Disease
Tamara Isakova, Thomas L Nickolas
Current Opinion in Nephrology and Hypertension
|
April 28, 2018
Management of stones and bones: reduction of uncertainty through research
Tamara Isakova, David A Bushinsky
Kidney International
|
October 30, 2010
FGF23 or PTH: which comes first in CKD ?
Tamara Isakova, Myles S Wolf
Clinical Journal of the American Society of Nephrology : CJASN
|
August 21, 2007
Calcium, calcimimetics and clinical outcomes
Geoffrey Block
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 26, 2022
A Klotho-Derived Peptide as a Possible Novel Drug to Prevent Kidney Fibrosis
Tamara Isakova, Christopher Yanucil, Christian Faul
Clinical Journal of the American Society of Nephrology : CJASN
|
May 11, 2018
Microbiome and Cardiovascular Disease in CKD
Anna Jovanovich, Tamara Isakova, Jason Stubbs
Journal of the American Heart Association
|
August 23, 2023
Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney Disease
Daniel Edmonston, Tamara Isakova, Myles Wolf, et al.
Kidney International
|
July 17, 2009
A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease
Tamara Isakova, Orlando M Gutiérrez, Myles Wolf
Page
of 20